Piasky
NDC 50242-115, Crovalimab, injection, solution, from Genentech, Inc..
- Product NDC
- 50242-115
- Status
- Listed
- Labeler
- Genentech, Inc.
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761388
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/50242-115 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CROVALIMAB340 mg/2mL
Pharmacologic classes
Complement C5 Inhibitor [EPC]; Complement C5 Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 50242-115-01 | 50242011501 | 1 VIAL, SINGLE-USE in 1 CARTON (50242-115-01) / 2 mL in 1 VIAL, SINGLE-USE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/2597efc2-a97b-487c-b500-a67fd282a73bMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=50242-115
Use it
Look up 50242-115 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/50242-115 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 50242-115. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.